Search results for "After treatment"

showing 10 items of 80 documents

Morphological Changes Induced by Dextran Sulfate 500 in Mononuclear Phagocytes of Listeria-Infected Mice

1974

Morphological changes involving mononuclear phagocytes in Listeria -infected mice after treatment with dextran sulfate 500 were investigated. Mononuclear phagocytes in livers and spleens, both circulating monocytes and fixed macrophages, showed uptake of electron-dense material. Mononuclear phagocyte changes were most pronounced within granulomatous lesions, where many phagocytes showed large membrane-bound inclusions and extensive cellular damage. It is concluded that dextran sulfate 500 selectively damages mononuclear phagocytes and that, in listerial infection, dextran sulfate 500 renders mononuclear phagocytes unable to express cellular resistance.

Infectious DiseasesDextran sulfateImmunologyImmunologyListeriaParasitologyMononuclear phagocyte systemBiologybiology.organism_classificationMicrobiologyGranulomatous lesionsAfter treatmentMicrobiology
researchProduct

Oral colonization by Candida species in orthodontic patients before, during and after treatment with fixed appliances: A prospective controlled trial

2020

Este artículo se encuentra disponible en la siguiente URL: http://www.medicinaoral.com/medoralfree01/aop/57565.pdf Background: Orthodontic treatment with fixed appliances is associated with changes in oral microbiota, including increased Candida colonization. The Candida fungus can cause oral lesions and infections such as candidiasis and angular cheilitis, and is harmful to both the patient and the orthodontist. Poor hygiene facilitates the colonization of these microorganisms. The key aim was to quantify the colonization of C. albicans in patients prior to beginning orthodontic treatment, and during the treatment process. Material and Methods: A total of 124 patients (43 males and 80 fema…

MEDLINEDentistryOrthodonticsOrthodontics.law.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawOrtodoncia.MedicineColonizationGeneral Dentistry0303 health sciences030306 microbiologybusiness.industryResearch030206 dentistry:CIENCIAS MÉDICAS [UNESCO]Candida Albicans - Treatment.Fungicidas.UNESCO::CIENCIAS MÉDICASCándida albicans - Tratamiento.businessAfter treatmentFungicides.Journal of Clinical and Experimental Dentistry
researchProduct

Effect of Riboflavin/UVA Collagen Cross-linking on Central Cornea, Limbus and Intraocular Pressure. Experimental Study in Rabbit Eyes

2016

The Purpose of present study was to investigate the effect of riboflavin/ultraviolet-A-induced collagen cross-linking (CXL) on central cornea, limbus and intraocular pressure (IOP). This was an animal experimental study. The right corneas of 10 rabbits were ultraviolet-A irradiated (3 mW/cm2 for 30 minutes) after de-epithelialization and instillation of 0.1% riboflavin / 20% Dextran drops. Left corneas served as controls. Samples were examined histologically one month postoperatively. Before and after treatment, IOP measurements were recorded bilaterally. At central cornea of eyes underwent CXL keratocyte repopulation, normal arrangement of collagen fibres and a statistically significant ch…

Male0301 basic medicineIntraocular pressuremedicine.medical_specialtyCollagen cross linkinggenetic structuresUltraviolet RaysIntraocular pressureRiboflavinlcsh:MedicineRiboflavinLimbus CorneaeCornea03 medical and health sciences0302 clinical medicineCollagen fibresOphthalmologyCorneamedicineAnimalsLimbusPhotosensitizing Agentsbusiness.industrylcsh:RSignificant differenceCorneal CrosslinkingGeneral Medicineeye diseasesCross-Linking Reagents030104 developmental biologymedicine.anatomical_structure030221 ophthalmology & optometryCollagenRabbitssense organsCentral corneabusinessAfter treatmentActa Medica (Hradec Kralove, Czech Republic)
researchProduct

Treatment of hyperthyroidism with radioiodine targeted activity: A comparison between two dosimetric methods.

2016

Radioiodine therapy is an effective and safe treatment of hyperthyroidism due to Graves' disease, toxic adenoma, toxic multinodular goiter. We compared the outcomes of a traditional calculation method based on an analytical fit of the uptake curve and subsequent dose calculation with the MIRD approach, and an alternative computation approach based on a formulation implemented in a public-access website, searching for the best timing of radioiodine uptake measurements in pre-therapeutic dosimetry. We report about sixty-nine hyperthyroid patients that were treated after performing a pre-therapeutic dosimetry calculated by fitting a six-point uptake curve (3-168h). In order to evaluate the res…

MaleRadioiodine uptakeBiophysicsGeneral Physics and AstronomyHyperthyroidism030218 nuclear medicine & medical imagingIodine Radioisotopes03 medical and health sciences0302 clinical medicineTreatment planMultinodular goiterDosimetryMedicineHumansRadiology Nuclear Medicine and imagingInternal dosimetryRadiometryAgedbusiness.industryRadioiodine therapyGeneral MedicineMiddle AgedBiokinetics Hyperthyroidism Internal dosimetry Radioiodine therapy030220 oncology & carcinogenesisPatient dosimetryFemaleNuclear medicinebusinessAfter treatmentFollow-Up StudiesPhysica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)
researchProduct

Evaluation of the xerostomia, taste and smell impairments after Covid-19

2021

Background The purpose of this study was to explore the effects of coronavirus disease 19 (Covid-19) on the oral cavity by evaluating the oral findings in the patients who recovered after treatment. Material and Methods This study involved confirmed Covid-19 patients whose treatment completed at least two weeks ago. A questionnaire consist of eight parts was applied to explore the oral findings after Covid-19. Also stimulated salivary flow rate was evaluated with a salivary flow test. Results 177 patients reached and 107 of them participate in the study. Regarding gender significant differences were found in terms of the presence of taste impairment after treatment (p=0.007), the degree of …

MaleTastemedicine.medical_specialty2019-20 coronavirus outbreakguided surgeryCoronavirus disease 2019 (COVID-19)dynamic guided surgeryOral cavityXerostomiaTaste Disordersdynamic navigationInternal medicineHumansMedicineIn patientTreatment completedGeneral DentistryUNESCO:CIENCIAS MÉDICASOral Medicine and PathologySARS-CoV-2business.industryResearchCOVID-19Salivary flow rateSmellOtorhinolaryngologycomputer assisted surgeryTasteFemaleSurgerybusinessAfter treatment
researchProduct

Administration of triclabendazole is safe and effective in controlling fascioliasis in an endemic community of the Bolivian Altiplano.

2012

Background The Bolivian northern Altiplano is characterized by a high prevalence of Fasciola hepatica infection. In order to assess the feasibility, safety and efficacy of large-scale administration of triclabendazole as an appropriate public health measure to control morbidity associated with fascioliasis, a pilot intervention was implemented in 2008. Materials and Methods Schoolchildren from an endemic community were screened for fascioliasis and treated with a single administration of triclabendazole (10 mg/kg). Interviews to assess the occurrence of adverse events were conducted on treatment day, one week later, and one month after treatment. Further parasitological screenings were perf…

MaleVeterinary medicineEndemic DiseasesNon-Clinical Medicinemedicine.medical_treatmentRC955-962Arctic medicine. Tropical medicineMedicineChildAnthelminticsbiologyTreatment OutcomeInfectious DiseasesTriclabendazoleChild PreschoolMedicineFemalePublic HealthPublic aspects of medicineRA1-1270After treatmentResearch Articlemedicine.drugSingle administrationBoliviaFascioliasismedicine.medical_specialtyAdolescentDrug-Related Side Effects and Adverse ReactionsChemopreventionInterviews as TopicInternal medicineparasitic diseasesAnimalsHumansFasciola hepaticaAdverse effectTriclabendazoleTreatment GuidelinesChemotherapyHealth Care Policybusiness.industryPublic healthPublic Health Environmental and Occupational HealthDrug PolicyFasciola hepaticabiology.organism_classificationParasitologyBenzimidazolesPreventive MedicinebusinessPLoS Neglected Tropical Diseases
researchProduct

Treatment of cryptorchidism with a potent analog of gonadotropin-releasing hormone.

1978

Pernasal therapy of cryptorchidism with D-Leu6-des-Gly10-gonadotropin-releasing hormone ethylamide (D-Leu6-des-Gly10-GnRH-EA), a potent, long-acting GnRH analog, was attempted. Eleven prepubertal cryptorchid boys received between 25 microgram once daily and 25 to 50 microgram twice daily for 5 to 12 weeks. Complete testicular descent was achieved in 4 of the 11 boys. GnRH tests (1.5 microgram/kg intravenously), conducted in six boys before treatment, after 4 weeks of treatment, and in 2 boys 3 months after treatment, did not reveal changes in gonadotropin secretion indicative of precocious puberty or of decreased hypophyseal sensitivity to GnRH. Antibodies to the GnRH analog or to GnRH coul…

Maleendocrine systemmedicine.medical_specialtyTime FactorsGonadotropin-releasing hormoneInternal medicineCryptorchidismMedicinePrecocious pubertyHumansChildbusiness.industryObstetrics and GynecologyInfantGnRH AnalogLuteinizing Hormonemedicine.diseaseGonadotropin secretionEndocrinologyReproductive MedicineChild PreschoolAntibody FormationOnce dailyFollicle Stimulating HormonebusinessPituitary Hormone-Releasing Hormoneshormones hormone substitutes and hormone antagonistsAfter treatmentGonadotropinsHormoneFertility and sterility
researchProduct

Lung ultrasound in outpatients with heart failure: the wet‐to‐dry HF study

2021

The Nancy team is supported by the RHU Fight-HF, a public grant overseen by the French National Research Agency (ANR) as part of the second 'Investissements d'Avenir' programme (reference: ANR-15-RHUS-0004), by the French PIA project 'Lorraine Université d'Excellence' (reference: ANR-15-IDEX-04-LUE), the ANR FOCUS-MR (reference: ANR-15-CE14-0032-01), ERA-CVD EXPERT (reference: ANR-16-ECVD-0002-02), the Contrat de Plan Etat Lorraine IT2MP, and FEDER Lorraine. Aims: In ambulatory patients with chronic heart failure (HF), congestion and decongestion assessment may be challenging. The aim of this study is to assess the value of lung ultrasound (LUS) in outpatients with HF in characterizing deco…

Malemedicine.medical_specialtyHeart failure030204 cardiovascular system & hematologyPulmonary congestion03 medical and health sciences0302 clinical medicine[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemInterquartile rangeInternal medicineOutpatientsmedicineHumansDiseases of the circulatory (Cardiovascular) systemDecompensation030212 general & internal medicineLungUltrasonographyHeart FailureLung ultrasoundbusiness.industryHazard ratioOriginal ArticlesPrognosismedicine.diseaseConfidence interval[SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system3. Good healthLung ultrasoundRC666-701Heart failureAmbulatoryCardiologyOriginal ArticleFemaleCardiology and Cardiovascular MedicinebusinessAfter treatmentESC Heart Failure
researchProduct

Association between general and oral health-related quality of life in patients treated for oral cancer

2015

Background Less is known about the association between general health-related quality of life (HRQoL) and oral HRQoL (OHRQoL) among patients with specific diseases. The aim of this study was to assess the association between patient-centered outcome measurements (HRQoL and OHRQoL) of oral cancer patients at least 6 months after treatment. Material and Methods HRQoL was measured with the 12-Item Short Form Health Survey (SF-12); OHRQoL was evaluated using the Oral Health Impact Profile (OHIP-14) and the Oral Impacts on Daily Performances (OIDP). Results Higher OHRQoL scores were associated with lower SF-12 domains scores. The OHIP-14 explained 16.5 % of the total variance of SF-12 Physical C…

Malemedicine.medical_specialtyPediatricsTime FactorsPsychological interventionOral HealthOdontologíaOral healthQuality of lifeSurveys and QuestionnairesInternal medicinemedicineHumansIn patientAssociation (psychology)General DentistryAgedMouth neoplasmOral Medicine and Pathologybusiness.industryResearchCancerMiddle Agedmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludhumanitiesPatient Outcome Assessmentstomatognathic diseasesOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASQuality of LifeFemaleMouth NeoplasmsSurgerybusinessAfter treatment
researchProduct

Lower self-reported depression in patients with erectile dysfunction after treatment with sildenafil

2001

Abstract Background: Depressive symptoms in men with erectile dysfunction (ED) may improve under successful ED treatment. Self-reported depressive symptoms were compared in men with ED after sildenafil treatment to a group of untreated patients. Methods: In an open study, self-reported depressive symptoms of 54 men after successful treatment with sildenafil (>4 weeks) and 51 men awaiting ED treatment were investigated with the Center of Epidemiologic Studies–Depression Scale (CES–D). CES–D items were subjected to an exploratory factor analysis and group differences in CES–D items and factors were analyzed. Results: Groups were comparable with respect to demographic characteristics and illne…

Malemedicine.medical_specialtyPersonality InventoryDepression scaleSildenafilmedia_common.quotation_subjectPiperazinesSildenafil Citratechemistry.chemical_compoundErectile DysfunctionInternal medicinemedicineHumansIn patientSulfonesRisk factorDepression (differential diagnoses)Agedmedia_commonSelection biasDepressionMiddle Agedmedicine.diseasePsychiatry and Mental healthClinical PsychologyCross-Sectional StudiesTreatment OutcomeErectile dysfunctionchemistryPurinesPsychologyAfter treatmentClinical psychologyJournal of Affective Disorders
researchProduct